Immune Status in Solid Organ Transplantation

Dartmouth-Hitchcock Medical Center20 enrolled

Overview

Immunosuppressive therapy protocols in solid organ transplantation are rudimentary, differ by transplant center and no practical strategies are available to guide an individuals' response to immune suppression. In this study we will conduct research to assess immunologic status in solid organ transplant recipients, predicting immune reconstitution and outcomes after transplant to better guide the use of immunosuppressive medications.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Organ Transplants

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Impending kidney transplant * Age \>18 * Able to provide informed consent and comply with the study procedures Exclusion Criteria: * Age\<18 * Concomitant illness, which by decision of investigator, may compromise the ability to perform this trial

Locations (1)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Outcomes

Primary Outcomes

Immune Markers

Time frame: 0, 3, 6, 9, 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.